FRE:
The current market price is 73.97, remaining unchanged from the previous close.
Support and Resistance Levels
Support levels are at 73.97, 73.97, and 73.97. Resistance levels are also at 73.97, 73.97, and 73.97. The pivot point is 73.97.
Indicators
The RSI is at 100, indicating overbought conditions. The ATR and ADX are absent, while Parabolic SAR is at 73.97. All moving averages (SMA and EMA) are also at 73.97.
Market Sentiment
The price at 73.97 aligns with resistance; expect a corrective pullback unless supported by other indicators.
FRE Signals & Technical Analysis
Last Updated: <% indicators.interval.updated|date:'MMM d, y h:mm:ss a' %>
Fresenius SE & Co. KGaA, a global healthcare group based in Germany, is dedicated to providing high-quality products and services across the healthcare spectrum. Established in 1912, Fresenius has evolved into a leading provider of innovative solutions, encompassing clinical nutrition, dialysis, and medical devices, among other areas. The company operates through various subsidiaries, including Fresenius Medical Care, Fresenius Kabi, and Fresenius Helios, each specializing in different segments of the healthcare market.
Market Position
Fresenius holds a strong market position in the global healthcare industry, with a presence in over 100 countries. As a leader in dialysis services and products, Fresenius Medical Care is the world’s largest provider of dialysis treatments, catering to over 350,000 patients daily. Fresenius Kabi focuses on infusion therapy and clinical nutrition, supplying essential drugs and medical technology that ensure patient safety and enhance treatment outcomes. Meanwhile, Fresenius Helios operates one of the largest private hospital chains in Germany, emphasizing quality care and operational efficiency.
Key Financial Highlights
Fresenius SE & Co. KGaA has consistently demonstrated strong financial performance, supported by a robust business model and diversified healthcare offerings. For the fiscal year 2022, the company reported revenues exceeding €37 billion, reflecting a steady growth trajectory fueled by increasing demand for healthcare services globally. The company’s commitment to innovation and quality has not only solidified its leadership position but also enhanced its competitive edge in the market.
Industry Trends and Outlook
The healthcare sector is witnessing significant transformations driven by technological advancements, an aging population, and a growing emphasis on chronic disease management. Fresenius is well-positioned to capitalize on these trends through strategic investments in research and development, alongside expanding its product lines and services. With a commitment to sustainability and patient-centric approaches, Fresenius SE & Co. KGaA aims to continue leading the way in delivering exceptional healthcare solutions, ensuring optimal patient outcomes in the evolving landscape of global health.
<% (signals.list.current.rate).substr(0,7) %>
<% signal.analyst %>
